02269
港股医药股午后走弱，昭衍新药(06127.HK)、药明康德(02359.HK)跌超5%，药明生物(02269.HK)、泰格医药(03347.HK)等跟跌。
时间：2024-11-13 13:51:41 市场： 综合 港股
【药明康德、药明生物回应出售业务传言：正评估运营选项，定期业务审查】 金十数据10月4日讯，有报道称，药明康德和药明生物正在着手出售部分业务，其中药明康德将出售WuXi Advanced Therapies，讨论已经进行了数月，已接洽合同制造商对手以收购全部或部分资产。10月4日，药明康德方面向记者表示，我们正在评估继续WuXi Advanced Therapies（高端治疗业务）运营的选项，以符合我们的优先事项：我们的员工以及需要基本的、时间要求严格的、救命治疗的患者。
时间：2024-10-04 11:46:26 市场： 综合 港股
港股生物医药股午后直线拉升，药明生物(02269.HK)、药明康德(02359.HK)均涨超6%，泰格医药(03347.HK)涨近4%，百济神州(06160.HK)、金斯瑞生物科技(01548.HK)均涨超2%。
时间：2024-09-20 15:21:56 市场： 综合 港股 美股
China Condemns US House's Passing of Bill Targeting Biotech Companies China has opposed a bill passed by the US House of Representatives that imposes sanctions on several Chinese biotech companies.A spokesperson from China's Foreign Ministry described the US measures as "discriminatory" and urged the US to abandon its "ideological bias.""China will continue working to protect the lawful and legitimate rights and interests of Chinese companies and support them in safeguarding their own rights and interests in accordance with the law," Foreign Ministry spokesperson Mao Ning told reporters on Tuesday.WuXi Biologics (Cayman) (HKG:2269) and WuXi AppTec (HKG:2359, SHA:603259) are among the Chinese companies targeted by the Biosecure Act, accusing them of collecting genome data.
时间：2024-09-11 11:23:50 市场： 综合 港股 A股